RGRX

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 1/17/2017
Contact Info
  • 15245 Shady Grove Road
  • Suite 470
  • Rockville, MD 20850

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000707511
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1982
Employees Not Available
Company Officers/Contacts
J.J. Finkelstein President, CEO
Dane Saglio CFO
Lori Smith Administrator
Company Directors
Allan L. Goldstein Chairman
Mauro Bove
Don Elsey
Joseph C. McNay
Service Providers
Accounting/Auditing Firm
CohnReznick LLP
8045 Leesburg Pike
Suite 240
Vienna, VA, 22182
United States
 
Securities Counsel
Fredrikson & Byron, P.A.
200 S. Sixth St.
Suite 4000
Minneapolis, MN, 55402
United States
 
Investor Relations Firm
PCG Advisory Group
535 Fifth Avenue
24th Floor
New York, NY, 10017
United States
 
Company History
  • Formerly=Alpha 1 Biomedicals, Inc. until 12-00
RGRX Security Details
Share Structure
Market Value1 $32,036,145 a/o Feb 24, 2017
Authorized Shares 200,000,000 a/o Sep 30, 2016
Outstanding Shares 106,787,151 a/o Nov 11, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 45,819,317 a/o May 14, 2015
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
American Stock Transfer & Trust Company
Shareholders
Shareholders of Record 745 a/o Apr 11, 2016
Short Selling Data
Short Interest 2,763 (46.97%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security